SecBot SecBot
6-K ·Filed May 6, 2026

ARGX

ARGENX SE
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001104659-26-056296
Notable filing: 6-K
Actionable Insight • Neutral

The CEO transition is routine and founder remains as Chair, so no immediate trading catalyst. Monitor any strategic updates from new CEO in upcoming quarters; the share issuance authorization may be used for future financing or acquisitions.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$787.31
T+0 close · May 6, 2026 · via day close
Latest settled
+5.52%
T+60 · $830.79
Vs SPY
+1.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $787.31entry
  2. T+1 · 6mo ago 0.00%α −0.83% · $787.31
  3. T+5 · 6mo ago +1.95%α +0.45% · $802.70
  4. T+20 · 6mo ago +3.28%α +0.14% · $813.14
  5. T+60 · 4mo ago +5.52%α +1.69% · $830.79
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

argenx announced results of its Annual General Meeting and the appointment of Karen Massey as CEO, succeeding founder Tim Van Hauwermeiren who becomes Chair. Shareholders approved all agenda items, including a 10% share issuance authorization. The leadership transition is orderly and the founder remains involved, limiting disruption risk.

Key Facts

  • Karen Massey appointed CEO effective immediately, succeeding founder Tim Van Hauwermeiren.
  • Tim Van Hauwermeiren appointed Chairperson of the Board.
  • All agenda items approved at AGM, including 2025 remuneration report and annual accounts.
  • Authorization to issue up to 10% of outstanding shares for 18 months, with pre-emptive rights exclusion possible.
  • 90.9% of share capital represented at the meeting.

Financial Impact

No direct financial impact disclosed. Share issuance authorization could lead to dilution up to 10%.

dilution

Risk Factors

  • Execution risk under new CEO if strategic direction changes materially.
  • Potential dilution if share issuance authorization is utilized.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-056296
Document: tm2613815d1_6k.htm0001104659-26-056296
Document: 0001104659-26-056296-index-headers.html0001104659-26-056296
Document: 0001104659-26-056296-index.html0001104659-26-056296
Document: 0001104659-26-056296.txt0001104659-26-056296

Track record

23 reports on ARGX

Performance horizon

7 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +30.22% at T+60 after the Jun 3, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 9, 20267d ago 6-K Bullish 6/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
  2. Nov 9, 20267d ago 6-K Neutral 5/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
  3. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $962.27 Now $950.95 −1.18% settles Dec 8
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $894.77 Now $950.95 +6.28% settles Dec 4
  5. Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $897.85 Now $950.95 +5.91% settles Nov 27
  6. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $875.76 Now $950.95 +8.59% settles Nov 19
  7. Oct 19, 202628d ago 6-K Bullish 7/10 Entry $825.61 to $950.95 Now $950.95 +15.18% ▲ +15.18% +18.64% vs SPY
  8. Oct 8, 20265w ago 6-K Mixed 6/10 Entry $818.63 to $931.38 Now $950.95 +16.16% ▲ +13.77% +19.06% vs SPY
  9. Sep 29, 20266w ago 6-K Bullish 6/10 Entry $970.66 to $871.52 Now $950.95 −2.03% ▼ −10.21% −10.87% vs SPY
  10. Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $984.04 to $818.63 Now $950.95 −3.36% ▼ −16.81% −18.93% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026